Asian student entrepreneurs dominate the final reckoning in a Cambridge University business competition encouraging student entrepreneurship.
Proudly presented by CUE.
Date and Time: 18:00 – 22:00 Wednesday, 8 June, 2011
Location: Cambridge Union, The Chamber
A showcase of the business ideas from this year’s finalists of the CUE entrepreneurs’ challenge. They will be pitching to a penal of angel investors, hoping to win the grand CUE prize of £5000 and maybe even the special Angel Prize!
The finalists are:
Anharmonika: Sourav Ghosh, Ashley Butcher
e-Comm: Tongyun Li, Michael Crips, Richard Penty, Ian White
Spherico Biotechnology: Shah rukh Abbas, Faisal Khan, Habib Abdur-Rahman
Trainsense: He Yu, Ruiqi Chen, Sinha dhiraj
RISE: Baillie Aaron, Daniel Marshall
Craftslink: Rudradeb Mitra, Ali Marjowy, Steve Power
Elpida Cambridge Health: Muntaqa Umar-sadiq, Lu Tan, Michael Freeman
Green Pace: Sargam Tyagi, Anuja Sinha
Khadija’s Business Park: Shah rukh Abbas, Faisal Khan, Habib Abdur-Rahman
Stella: Wenqi Chen
Qiqqa: James Jardine, Nicholas Smit, Elbert Marais, James Phillips
Labbridge: Min Hu, Peng Li, Ankur Mutreja
The competition is fierce and entertaining, and all you need to do is to come along and enjoy the night with a glass of champaign on the house!
18:00 Arrival and Registration
18:30 Welcome from the President
18:35 Introduction to the Panel
18:50 CUE Finalists Pitches
19:40 CUE review and pitches from CUE competition entrants
20:00 Winners announced
20:30 Poster session, Food, Drinks, Cake and Live music
This year’s angel investors:
Charles Cotton – Serial Entrepreneur and founder and Chairman of Cambridge Phenomenon Ltd
Charles Cotton is an experienced director of public companies listed on the London, Nasdaq, Euronext Amsterdam, and Frankfurt stock exchanges and private companies in the USA and Europe.
During his career he has lived and worked in the UK, USA and Germany and has experience conducting business in Europe, the Middle East, Asia, North America and Africa. He has advised the UK government on the development of entrepreneurial businesses and the commercialization of science and technology. In addition, he is an adviser to and investor in venture capital firms, an angel investor and mentor.
He is a director of Solarflare, the semiconductor company; Veebeam, the consumer electronics company; and two other companies in California. His UK directorships include Cambridge Phenomenon Ltd, semiconductor company XMOS and Cambridge Enterprise Ltd the organization within the University of Cambridge responsible for spin-outs, licensing and consulting activities.
Jonathan Milner is a highly experienced entrepreneur and business leader with a background in genetic research. He gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath University. He was a research fellow at Bath University and the University of Cambridge in the laboratory of Professor Tony Kouzarides, studying genes and proteins associated with human cancers. Whilst working in research he identified the potential market opportunity in supplying high quality antibodies to support protein interaction studies. He founded Abcam, with David Cleevely and Professor Tony Kouzarides, in February 1998 as an internet-based business to supply a rapidly growing market. He is an active member of the Cambridge, UK, business community and is chairman of Cambridge Temperature Concepts Limited, a Cambridge University Entrepreneurs (CUE) Entrepreneurs’ Challenge winning team, also a privately held medical device company developing a reliable system for ovulation monitoring.
Dr Andy Richards is a serial Biotechnology entrepreneur and business angel. He is currently Chairman of Altacor, Novacta and Ixico and is a director of Vectura plc, Summit Corp plc, Theradeas, Cancer Research Technology (commercial arm of CR-UK) and Babraham Bioscience Technology.He is a Cambridge graduate with a PhD in Chemistry who spent his early career with ICI (now AstraZeneca) and with PA Technology. He was a founder of Chiroscience and an executive director through to the sale to Celltech in 1999. Since that time he has been founding and investing in new Cambridge based biotechnology companies including several of those listed above as well as Arakis, Geneservice, Cambridge Biotechnology Ltd, Amedis Pharmaceuticals, Sirus Pharmaceuticals, Daniolabs and Pharmakodex, all of which were recently sold.He is a council member of the Biotechnology and Biological Sciences Research Council (BBSRC), a founder member of the Cambridge Angels, the founding Chairman of BIA Bioangels.
Ted Shelton, CEO, Open-First. Open-First is a consulting firm based in Palo Alto and London working with clients ranging such as Alcatel-Lucent, General Motors, and ThomsonReuters on innovation and market ecosystem projects. Ted has spent the past 20 years working in the high tech industry, as a software developer, in product development, marketing, and as a senior executive in both public and privately held companies. Previously Shelton served as the Chief Strategy Officer of Borland Software and Senior VP of Sales and Marketing for WhoWhere (acquired by Lycos in 1998) and several other software and Internet start-up companies.